PRICE T ROWE ASSOCIATES INC /MD/
Position in MDGL — Madrigal Pharmaceuticals, Inc.
CIK 80255
BALTIMORE, MD
Position in MDGL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$171,755,740
-$10,900,441 QoQ
Shares Held
328,110
+4.6% QoQ
Ownership
1.42%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.89576666361891.ToString("F0")%
Shared 0.ToString("F0")%
None 0.10423333638109171.ToString("F0")%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $14,300,473,279 across 256 Biotechnology names. MDGL ranks #20 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
3,374,955 | $2,464,560,888 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,177,527 | $1,682,444,460 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,760,122 | $785,964,877 | |
| 4 | INSM |
INSMED Inc
|
3,092,807 | $505,735,799 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
6,060,847 | $504,807,946 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,432,748 | $474,053,330 | |
| 7 | ASND |
Ascendis Pharma A/S
|
1,530,345 | $350,035,811 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
3,232,213 | $314,332,713 |
All Filings in MDGL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $171,755,740 | 328,110 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $182,656,181 | 313,659 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $161,686,822 | 352,520 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $153,881,544 | 508,464 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $179,736,328 | 542,633 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $181,674,906 | 588,764 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $155,705,177 | 733,697 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $240,591,602 | 858,765 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $214,489,998 | 803,213 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $89,944,115 | 388,729 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $24,881,272 | 170,373 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $12,798,093 | 55,403 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $11,386,219 | 47,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $16,036,312 | 55,250 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,029,898 | 46,621 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,035,135 | 42,402 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,405,489 | 44,899 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $4,105,907 | 48,453 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $4,611,862 | 57,800 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $7,427,999 | 76,255 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $10,005,730 | 85,541 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $19,033,304 | 171,209 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $20,854,330 | 175,645 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $16,305,168 | 143,975 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $3,118,893 | 46,718 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||